Viz.ai aims to use artificial intelligence and deep learning to automatically identify suspected LVOs (large vessel occlusion) on CTA imaging with the aim of alerting a patient's physician within minutes. The company was founded in 2016 and is based in San Francisco, California.
Subtle Medical is a medical imaging software company that develops a suite of deep learning software solutions to improve image quality and enable up to 4x faster scan times for PET and MRI. SubtleMR and SubtlePET utilize deep learning algorithms that integrate with any scanner and PACS system with no change in the imaging specialists’ workflow.
Zebra Medical Visions provides an imaging analytics platform that allows healthcare institutions to identify patients at risk of diseases and offer improved, preventative treatment pathways to improve patient care.On August 10th, 2021, Zebra Medical Vision was acquired by Nanox at a valuation between $100M and $200M with $100 million upfront and another $100 million tied to specific milestones, all in stock.
Qure.ai has developed an artificial intelligence-based system to identify abnormalities in head CT scans. The company aims to leverage deep learning effectively to diagnose diseases from radiology and pathology imaging and create personalized cancer treatment plans from psychopathology imaging and genome sequences. It was founded in 2016 and is based in Mumbai, India.
Imagen is building a world without diagnostic errors. The company is beginning by applying the latest advances in computer vision and machine learning to medical imaging. Imagen Technologies is putting leading medical expertise in the hands of healthcare providers everywhere.
Alexander Dresner, Thomas Hotchkiss, Robert Lindsey, and 1 more
Nines develop services and technology that leverage applied machine learning to let radiologists focus their efforts on patient outcomes. The company’s debut software suite is designed to aid in prioritizing the radiological review of emergent cases based on the analysis of head CT images, potentially facilitating faster diagnoses for those patients that need it most, all with the objective of allowing providers to start treatment sooner. The Emergent Neuro Suite is intended for triage of cytotoxic edema, hemorrhage, and mass effect, all of which are exceptionally time-sensitive.On February 18th, 2022, Nines was acquired by Sirona Medical. Terms of the transaction were not disclosed.
David Stavens, Michael Kelleher, Max Ochoa, and 1 more
What is AI In Diagnostic Imaging?
Solutions that leverage machine learning and computer vision for image acquisition, disease detection, triaging, and diagnosis from ultrasounds, MRIs, CT scans, and more.
Selling a product or service? Reach more buyers.
Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.